A test using genetics to predict who is at the highest risk of developing type 1 diabetes could one day be applied to largescale health studies, to identify… read more.
Fresenius announced the launch of its denosumab biosimilars, Conexxence (denosumab) and Bomyntra (denosumab), in Europe. These biosimilars received approval from the European Commission in July 2025 for all… read more.
The European Medicines Agency’s key committee on human medicines (CHMP) recommended ten medicines for approval at its November 2025 meeting. This brings to 97 the total number of… read more.
Researchers report success in using pazopanib to treat young patients diagnosed with deadly Ewing’s sarcoma. They published their findings on Oct. 23, 2025 in Frontiers in Oncology As… read more.
University of Georgia researchers have developed a new type of hand sanitizer that eliminates more than 97% of bacteria and fungi, including antibiotic-resistant strains. The new gel provides an alternative… read more.
Researchers report that treating complicated Staphylococcus aureus bloodstream infections with two intravenous (IV) doses of the antibiotic dalbavancin seven days apart is as effective as treatment with daily… read more.
An international study led by researchers at the University of Colorado Anschutz Medical Campus has identified a promising strategy to enhance the safety of nanomedicines, advanced therapies often used in… read more.
A new study from Emory University addresses the growing global crisis of antibiotic-resistant infections. Many of these drug-resistant bacteria are spread through hospitals, and there are few antibiotics… read more.
Among patients with ongoing, uncontrolled hypertension in spite of treatment with indapamide, amlodipine, or olmesartan, the addition of a single dose of investigative zilebesiran has, at 3 months,… read more.
April was a bumper month for drug approvals in Europe, with sixteen new products recommended by the European Medicines Agency’s (EMA) key committee on human medicines. This almost… read more.
While prednisone is the standard first-line treatment for pulmonary sarcoidosis, side effects can diminish quality of life. Researchers report that methotrexate appears to have fewer side effects and… read more.
A preclinical study from scientists at Scripps Research finds that a drug already FDA-approved for treating inflammatory conditions may help reduce both alcohol intake and pain sensitivity—two issues… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
